Effect of protein synthesis inhibitors and low concentrations of actinomycin D on ribosomal RNA synthesis.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D003513:Cycloheximide / Q000494:pharmacology*; D004256:DNA Polymerase I / Q000378:metabolism*; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism*; D003609:Dactinomycin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D007700:Kinetics; D051379:Mice; D010142:Pactamycin / Q000494:pharmacology*; D012335:RNA, Ribosomal / Q000096:biosynthesis*; D014158:Transcription, Genetic / Q000187:drug effects*
D000903:Antibiotics, Antineoplastic; D012335:RNA, Ribosomal; D003609:Dactinomycin; D010142:Pactamycin; D003513:Cycloheximide; D004256:DNA Polymerase I; D004259:DNA-Directed DNA Polymerase